Cell Reports Medicine SCIE

国际简称：Cell Rep Med 参考译名：细胞医学报道

主要研究方向：Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all) 非预警期刊审稿周期：约Time to desk decision: 6.6 days; Publication time: 3.31 weeks 17 Weeks

《细胞医学报道》(Cell Reports Medicine)是一本由Elsevier出版的以Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本开放期刊，近三年没有被列入预警名单。该期刊享有很高的科学声誉，影响因子不断增加，发行量也同样高。

1区中科院分区
Q1 JCR分区
305 年发文量
11.7 IF影响因子
开放是否OA
2020 创刊年份
Monthly 出版周期
English 出版语言

Cell Reports Medicine is a premium open-access journal from Cell Press publishing cutting-edge research in translational and clinical biomedical sciences that inform and influence human health and medicine.

The content published in Cell Reports Medicine reaches a broad range of scientists and clinicians across the spectrum of medical disciplines, ensuring that your work will be both visible and accessible. The journal publishes original research that ranges from exciting concepts in human biology, health, and disease to all phases of clinical work. We encourage submissions featuring innovative ideas that open up new directions in clinical research and practice, as well as studies that provide critical information that enriches our understanding of current standards of care in diagnosis, treatment, and prognosis. This includes, but is not limited to, translational studies, clinical trials in all areas of medicine including long-term trial follow-ups as well as work in genomics, biomarker discovery, and developments in technology that contribute to diagnostics, treatment, and healthcare. Studies based on vertebrate model organisms also fall within the scope of the journal, provided that the results are directly relevant to human health and disease.

Like our sister journal Cell Reports, we will consider impactful, single-point papers called reports, in addition to longer articles. Large datasets, techniques, and tools for the community can also be considered under the article format. We will also publish reviews covering recent literature in emerging and active fields.

The professional in-house scientific editors at Cell Reports Medicine work closely with authors, reviewers, and the journal's editorial board to ensure exemplary editorial process, fair and robust peer review, and rapid dissemination and communication of your research.

[ 查看全部 ]

投稿咨询加急咨询

Cell Reports Medicine期刊信息

ISSN：2666-3791
出版语言：English
是否OA：开放
E-ISSN：2666-3791
出版地区：United States
是否预警：否
出版商：Elsevier
出版周期：Monthly
创刊时间：2020
开源占比：0.8876
Gold OA文章占比：93.57%
OA被引用占比：
出版国人文章占比：0
出版撤稿占比：
研究类文章占比：95.74%

Cell Reports Medicine CiteScore评价数据（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指数

4.276

1.664

学科类别	分区	排名	百分位
大类：Medicine 小类：General Medicine	Q1	25 / 636	96%
大类：Medicine 小类：General Biochemistry, Genetics and Molecular Biology	Q1	18 / 221	92%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Cell Reports Medicine中科院评价数据

中科院 2023年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 CELL BIOLOGY 细胞生物学	1区 2区

中科院 2022年12月升级版

Top期刊	综述期刊	大类学科		小类学科
是	否	医学	1区	MEDICINE, RESEARCH & EXPERIMENTAL 医学：研究与实验 CELL BIOLOGY 细胞生物学	1区 2区

Cell Reports Medicine JCR评价数据（2023-2024年最新版）

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CELL BIOLOGY	SCIE	Q1	22 / 205	89.5%
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	10 / 189	95%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CELL BIOLOGY	SCIE	Q1	14 / 205	93.41%
学科：MEDICINE, RESEARCH & EXPERIMENTAL	SCIE	Q1	8 / 189	96.03%

Cell Reports Medicine历年数据统计

影响因子

中科院分区

Cell Reports Medicine中国学者发文选摘

1、Current understanding of the intratumoral microbiome in various tumors
Author: Xue, Chen; Chu, Qingfei; Zheng, Qiuxian; Yuan, Xin; Su, Yuanshuai; Bao, Zhengyi; Lu, Juan; Li, Lanjuan

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100884
2、Inherited mutations in Chinese patients with upper tract urothelial carcinoma
Author: Wu, Junlong; Jin, Shengming; Gu, Chengyuan; Wei, Yu; Zhu, Yao; Necchi, Andrea; Shariat, Shahrokh F.; Pan, Jian; Gan, Hualei; Dai, Bo; Zhang, Hailiang; Shi, Guohai; Zhu, Yu; Shen, Yijun; Zhu, Yiping; Ye, Dingwei

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100883
3、Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases
Author: Guo, Jiawei; Wang, Fuxiao; Hu, Yan; Luo, Ying; Wei, Yan; Xu, Ke; Zhang, Hao; Liu, Han; Bo, Lumin; Lv, Shunli; Sheng, Shihao; Zhuang, Xinchen; Zhang, Tao; Xu, Can; Chen, Xiao; Su, Jiacan

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 1, pp. -. DOI: 10.1016/j.xcrm.2022.100881
4、Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET
Author: Zhang, Qilin; Yao, Boyuan; Long, Xin; Chen, Zhengyuan; He, Min; Wu, Yue; Qiao, Nidan; Ma, Zengyi; Ye, Zhao; Zhang, Yichao; Yao, Shun; Wang, Ye; Cheng, Haixia; Chen, Hong; Ye, Hongying; Wang, Yongfei; Li, Yimin; Chen, Jianhua; Zhang, Zhaoyun; Guo, Fan; Zhao, Yao

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100934
5、Using patient-derived organoids to predict locally advanced or metastatic lung cancer tumor response: A real-world study
Author: Wang, Han-Min; Zhang, Chan-Yuan; Peng, Kai-Cheng; Chen, Ze-Xin; Su, Jun-Wei; Li, Yu-Fa; Li, Wen-Feng; Gao, Qing-Yun; Zhang, Shi-Ling; Chen, Yu-Qing; Zhou, Qing; Xu, Cong; Xu, Chong-Rui; Wang, Zhen; Su, Jian; Yan, Hong-Hong; Zhang, Xu-Chao; Chen, Hua-Jun; Wu, Yi-Long; Yang, Jin-Ji

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100911
6、Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma
Author: Tian, Xiao-Peng; Zhang, Yu-Chen; Lin, Ning-Jing; Wang, Liang; Li, Zhi-Hua; Guo, Han-Guo; Ma, Shu-Yun; An, Ming-Jie; Yang, Jing; Hong, Yu-Heng; Wang, Xian-Huo; Zhou, Hui; Li, Ya-Jun; Rao, Hui-Lan; Li, Mei; Hu, Shao-Xuan; Lin, Tong-Yu; Li, Zhi-Ming; Huang, He; Liang, Yang; Xia, Zhong-Jun; Lv, Yue; Liu, Yu-Ying; Duan, Zhao-Hui; Chen, Qing-Yu; Wang, Jin-Ni; Cai, Jun; Xie, Ying; Ong, Choon-Kiat; Liu, Fang; Liu, Yan-yan; Yan, Zheng; Huang, Liang; Tao, Rong; Li, Wen-Yu; Huang, Hui-Qiang; Cai, Qing-Qing

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100859
7、Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer
Author: Tang, Zhaoqing; Gu, Yuan; Shi, Zhongyi; Min, Lingqiang; Zhang, Ziwei; Zhou, Peng; Luo, Rongkui; Wang, Yan; Cui, Yuehong; Sun, Yihong; Wang, Xuefei

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2023.100931
8、DeepFundus: A flow-cytometry-like image quality classifier for boosting the whole life cycle of medical artificial intelligence
Author: Liu, Lixue; Wu, Xiaohang; Lin, Duoru; Zhao, Lanqin; Li, Mingyuan; Yun, Dongyuan; Lin, Zhenzhe; Pang, Jianyu; Li, Longhui; Wu, Yuxuan; Lai, Weiyi; Xiao, Wei; Shang, Yuanjun; Feng, Weibo; Tan, Xiao; Li, Qiang; Liu, Shenzhen; Lin, Xinxin; Sun, Jiaxin; Zhao, Yiqi; Yang, Ximei; Ye, Qinying; Zhong, Yuesi; Huang, Xi; He, Yuan; Fu, Ziwei; Xiang, Yi; Zhang, Li; Zhao, Mingwei; Qu, Jinfeng; Xu, Fan; Lu, Peng; Li, Jianqiao; Xu, Fabao; Wei, Wenbin; Dong, Li; Dai, Guangzheng; He, Xingru; Yan, Wentao; Zhu, Qiaolin; Lu, Linna; Zhang, Jiaying; Zhou, Wei; Meng, Xiangda; Li, Shiying; Shen, Mei; Jiang, Qin; Chen, Nan; Zhou, Xingtao; Li, Meiyan; Wang, Yan; Zou, Haohan; Zhong, Hua; Yang, Wenyan; Shou, Wulin; Zhong, Xingwu; Yang, Zhenduo; Ding, Lin; Hu, Yongcheng; Tan, Gang; He, Wanji; Zhao, Xin; Chen, Yuzhong; Liu, Yizhi; Lin, Haotian

Journal: CELL REPORTS MEDICINE. 2023; Vol. 4, Issue 2, pp. -. DOI: 10.1016/j.xcrm.2022.100912